India is called the pharmacy of the world during the COVID-19 pandemic with its vast experience and deep knowledge in medicine
The rollout of COVID-19 vaccine is "India's gift" to the world in combating coronavirus and will be remembered as a time when the country stepped up in a major way as a global player in innovation, a top American scientist has said.
FILE - In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer-BioNTech
COVID-19 vaccine at Tudor Ranch in Mecca, Calif. (AP)
07 Mar 2021
India is called the pharmacy of the world during the COVID-19 pandemic with its vast experience and deep knowledge in medicine. The country is one of the world’s biggest drug-makers and an increasing number of countries have already approached it for procuring coronavirus vaccines.
India is called the pharmacy of the world during the COVID-19 pandemic with its vast experience and deep knowledge in medicine. The country is one of the world’s biggest drug-makers and an increasing number of countries have already approached it for procuring coronavirus vaccines.
Dr. Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine (BCM) in Houston during a webinar this week said that the two mRNA vaccines may not impact the world's low and middle income countries, but India’s vaccines, made in collaboration with universities across the world such as BCM and Oxford University, have “rescued the world" and its contributions must not to be underestimated.
During the webinar, “COVID-19: Vaccination and Potential Return to Normalcy - If and When", Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.
India’s drugs regulator gave emergency use authorisation to Covishield, produced by Pune-based Serum Institute of India after securing licence from British pharma company AstraZeneca, and Covaxin, indigenously developed jointly by Hyderabad-based Bharat Biotech and Indian Council of Medical Research scientists.
The webinar was organised by Indo American Chamber of Commerce of Greater Houston (IACCGH).
“This is something very special and I see it myself because I'm on weekly teleconferences with our colleagues in India, you make a recommendation, and within days it's done and not only done, but it's done well and with incredible rigor and thought and creativity," Dr Hotez said, stressing that he felt compelled to make this statement because "India's huge efforts in combating global pandemic is a story that's not really getting out in the world."
Dr Hotez, considered as the authority on vaccinations, is working on an affordable coronavirus vaccine in collaboration with Indian pharmaceutical companies.
During the webinar, “COVID-19: Vaccination and Potential Return to Normalcy - If and When", Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.
India’s drugs regulator gave emergency use authorisation to Covishield, produced by Pune-based Serum Institute of India after securing licence from British pharma company AstraZeneca, and Covaxin, indigenously developed jointly by Hyderabad-based Bharat Biotech and Indian Council of Medical Research scientists.
The webinar was organised by Indo American Chamber of Commerce of Greater Houston (IACCGH).
“This is something very special and I see it myself because I'm on weekly teleconferences with our colleagues in India, you make a recommendation, and within days it's done and not only done, but it's done well and with incredible rigor and thought and creativity," Dr Hotez said, stressing that he felt compelled to make this statement because "India's huge efforts in combating global pandemic is a story that's not really getting out in the world."
Dr Hotez, considered as the authority on vaccinations, is working on an affordable coronavirus vaccine in collaboration with Indian pharmaceutical companies.
No comments:
Post a Comment